statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	891
DE - Germania	187
SG - Singapore	187
CN - Cina	170
SE - Svezia	118
VN - Vietnam	110
PL - Polonia	100
BR - Brasile	85
IT - Italia	64
FR - Francia	41
GB - Regno Unito	36
UA - Ucraina	33
IE - Irlanda	24
IN - India	18
FI - Finlandia	17
ID - Indonesia	17
BE - Belgio	15
HK - Hong Kong	15
TR - Turchia	14
CA - Canada	10
JP - Giappone	8
RU - Federazione Russa	8
BD - Bangladesh	7
AR - Argentina	6
MX - Messico	6
SA - Arabia Saudita	6
CO - Colombia	5
IL - Israele	5
KR - Corea	5
AU - Australia	4
ES - Italia	4
IQ - Iraq	4
IR - Iran	4
JO - Giordania	4
LT - Lituania	4
PK - Pakistan	4
PT - Portogallo	4
ZA - Sudafrica	4
CL - Cile	3
NL - Olanda	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
BO - Bolivia	2
CH - Svizzera	2
EC - Ecuador	2
IM - Isola di Man	2
LV - Lettonia	2
PA - Panama	2
RO - Romania	2
TW - Taiwan	2
AG - Antigua e Barbuda	1
AL - Albania	1
AO - Angola	1
AT - Austria	1
AZ - Azerbaigian	1
BG - Bulgaria	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EE - Estonia	1
GE - Georgia	1
GF - Guiana Francese	1
JM - Giamaica	1
KE - Kenya	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
MK - Macedonia	1
MY - Malesia	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
SK - Slovacchia (Repubblica Slovacca)	1
SO - Somalia	1
TH - Thailandia	1
TJ - Tagikistan	1
TN - Tunisia	1
UG - Uganda	1
VE - Venezuela	1
Totale	2.300

Nome	#
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD	341
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	241
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	194
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease	182
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease	181
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease	177
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases	170
Investigational prostaglandin D2 receptor antagonists for airway inflammation	170
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD	169
Dupilumab for the treatment of asthma	153
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	134
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers	115
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis	93
Totale	2.320

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	2	0	0	0	0	0	0	0	0	0	0	0	2
2021/2022	147	7	15	2	25	8	3	4	20	6	11	22	24
2022/2023	338	44	52	20	60	32	34	12	25	47	2	6	4
2023/2024	135	9	40	3	14	8	23	13	1	0	4	11	9
2024/2025	249	6	10	17	16	33	11	14	4	29	18	52	39
2025/2026	671	102	24	26	47	116	38	161	28	48	53	15	13
Totale													2.320

IRIS UniCatt